Adding tamper resistant properties to medications can help curb
prescription drug abuse
OTTAWA, June 26, 2015 /CNW/ - Health Canada today published a Notice of Pre-Consultation in Canada Gazette, Part I, seeking stakeholder feedback on draft
Tamper-Resistant Properties of Drugs Regulations. The draft regulations
would require that all controlled release oxycodone products have
tamper-resistant properties before they can be sold in Canada.
These draft regulations build upon the numerous initiatives the
Government is supporting to combat prescription drug abuse. The
Government of Canada invests approximately $130 million a year to
address addictions and drug abuse in Canada under the National Anti-Drug Strategy. These funds contribute to developing tangible and effective solutions
to the problems of drug addiction. In 2014, the government committed
over $44 million over five years to expand the focus of the National
Anti-Drug Strategy from illicit drugs to include measures to address
prescription drug abuse.
Over the past several months, the Government of Canada has taken a
number of steps to address prescription drug abuse, including:
launching a national marketing campaign to equip parents with the information and tools needed to talk with
their teenagers about the harmful effects of prescription drug abuse;
providing $13.5 million over five years to enhance prevention and
treatment services for prescription drug abuse in First Nations
launching the Canadian Research Initiative in Substance Misuse (CRISM),
a national research network aimed at improving the health of Canadians
living with substance misuse;
announcing nearly $8 million to support projects to improve prescriber
education and to support the development of a national approach to the
monitoring and surveillance of prescription drugs,
announcing nearly $13 million over five years to increase the number of
annual pharmacy inspections carried out by Health Canada; and,
releasing four promotional videos featuring personal stories from Canadians directly affected by
prescription drug abuse.
Canada is the world's second largest per capita consumer of prescription
In 2013, 22% of Canadians aged 15 and older reported using a
psychoactive prescription drug. Of these, 2% (about 146,000) reported
abusing the drug for non-medical purposes.
A comprehensive study on prescription drug abuse by the Standing
Committee on Health (HESA) recommended the Government consider the
merits of tamper-resistant drugs in addressing prescription drug abuse.
On May 15, 2015, the Minister of Health attended the Prescribing
Practices Forum in Hamilton, Ontario, bringing together regulatory
authorities, health professionals and experts in the field to identify
steps to improve prescribing practices, with the ultimate goal of
reducing the abuse of prescription drugs.
Minister Ambrose hosted a productive symposium on prescription drug
abuse in Edmonton on May 19, 2015, where she met with provincial
officials, doctors, pharmacists, First Nations representatives, law
enforcement and addictions specialists to discuss current challenges,
best practices and areas for further action under the National
"Prescription drug abuse is a significant public health and safety
concern. Adding tamper resistant properties to drugs at high risk of
abuse is an important component of our Government's comprehensive
approach to fighting prescription drug abuse."
Minister of Health
National Anti-Drug Strategy
Canadian Centre on Substance Abuse
SOURCE Health Canada
For further information:
Contacts: Michael Bolkenius, Office of the Honourable Rona Ambrose Federal Minister of Health, (613) 957-0200; Health Canada, Media Relations, (613) 957-2983; Public Inquiries: (613) 957-2991, 1-866 225-0709; Health Canada news releases are available on the Internet at: www.healthcanada.gc.ca/media